|
New Delhi, Jan 04: Drugs Controller General of India (DCGGI) on Monday granted permission to Serum Institute of India to manufacture its COVID-19 vaccine ‘Covishield’.
The manufacturer of the Covishield vaccine, plans to charge a special price of ₹200 per dose for the first 100 million shots that it supplies to the government, chief executive Adar Poonawalla said.
The company plans to price the vaccine at ₹1,000 per dose in the open market, once it is allowed to do so by the government, Poonawalla said in a telephonic interview.
Poonawalla further said that Serum Institute was in the process of signing a larger contract with COVAX for 300 million-400 million doses of the vaccine.
That is apart…
